(KSCP) Knightscope - Overview
Stock: Autonomous Security Robots, Emergency Communication Devices, Monitoring Software
EPS (Earnings per Share)
Revenue
| Risk 5d forecast | |
|---|---|
| Volatility | 157% |
| Relative Tail Risk | -13.5% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -0.55 |
| Alpha | -92.82 |
| Character TTM | |
|---|---|
| Beta | 1.731 |
| Beta Downside | 1.680 |
| Drawdowns 3y | |
|---|---|
| Max DD | 97.60% |
| CAGR/Max DD | -0.65 |
Description: KSCP Knightscope December 22, 2025
Knightscope, Inc. (NASDAQ:KSCP) designs, builds, and services autonomous security robots (ASRs) for U.S. customers. Its product portfolio includes the K3 indoor robot for offices, hospitals and malls; the K5 outdoor robot for parking lots, logistics sites and campuses; the stationary K1 Hemisphere unit; and the Knightscope Security Operations Center (KSOC), a cloud-based dashboard that lets clients monitor robot activity in real time. The company also sells solar-powered emergency communication hardware-K1 Blue Light Towers, K1 Blue Light E-Phones and K1 Call Boxes-plus a cloud-based management platform (KEMS) that tracks device health.
As of the latest quarterly filing (Q4 2023), Knightscope reported revenue of roughly $9.7 million, a year-over-year increase of about 30%, driven primarily by a growing backlog of multi-year contracts with corporate campuses and municipal entities. The firm has deployed over 500 robots to date, and its average contract length is 24 months, which helps smooth cash flow but also creates exposure to client budget cycles. Key sector drivers include a tightening labor market for security personnel, rising demand for contact-less safety solutions post-COVID, and municipal budget allocations for public-safety technology-factors that collectively expand the addressable market for autonomous security platforms.
If you want a more granular financial outlook, consider checking ValueRay’s detailed valuation models for KSCP to see how these operational trends translate into projected returns.
Piotroski VR‑10 (Strict, 0-10) 0.5
| Net Income: -29.7m TTM > 0 and > 6% of Revenue |
| FCF/TA: -0.64 > 0.02 and ΔFCF/TA 29.84 > 1.0 |
| NWC/Revenue: 160.9% < 20% (prev 0.05%; Δ 160.9% < -1%) |
| CFO/TA -0.60 > 3% & CFO -24.8m > Net Income -29.7m |
| Net Debt/EBITDA: error (EBITDA <= 0) |
| Current Ratio: 3.62 > 1.5 & < 3 |
| Outstanding Shares: last quarter (9.76m) vs 12m ago 220.9% < -2% |
| Gross Margin: -37.48% > 18% (prev -0.42%; Δ -3707 % > 0.5%) |
| Asset Turnover: 35.19% > 50% (prev 44.16%; Δ -8.97% > 0%) |
| Interest Coverage Ratio: -93.88 > 6 (EBITDA TTM -26.7m / Interest Expense TTM 313.0k) |
Altman Z'' -15.00
| A: 0.46 (Total Current Assets 25.8m - Total Current Liabilities 7.13m) / Total Assets 41.1m |
| B: -5.26 (Retained Earnings -216.0m / Total Assets 41.1m) |
| C: -0.89 (EBIT TTM -29.4m / Avg Total Assets 33.0m) |
| D: -15.25 (Book Value of Equity -215.9m / Total Liabilities 14.2m) |
| Altman-Z'' Score: -36.15 = D |
Beneish M -3.37
| DSRI: 0.99 (Receivables 2.46m/2.35m, Revenue 11.6m/11.0m) |
| GMI: 1.00 (fallback, negative margins) |
| AQI: 0.57 (AQ_t 0.28 / AQ_t-1 0.49) |
| SGI: 1.05 (Revenue 11.6m / 11.0m) |
| TATA: -0.12 (NI -29.7m - CFO -24.8m) / TA 41.1m) |
| Beneish M-Score: -3.37 (Cap -4..+1) = AA |
What is the price of KSCP shares?
Over the past week, the price has changed by +4.68%, over one month by -14.76%, over three months by -14.56% and over the past year by -67.40%.
Is KSCP a buy, sell or hold?
- StrongBuy: 2
- Buy: 1
- Hold: 0
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the KSCP price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 15 | 319% |
| Analysts Target Price | 15 | 319% |
| ValueRay Target Price | 2 | -43.6% |
KSCP Fundamental Data Overview February 05, 2026
P/B = 1.4291
Revenue TTM = 11.6m USD
EBIT TTM = -29.4m USD
EBITDA TTM = -26.7m USD
Long Term Debt = 4.00m USD (from longTermDebt, last quarter)
Short Term Debt = 425.0k USD (from shortTermDebt, last quarter)
Debt = 3.38m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = -17.0m USD (from netDebt column, last quarter)
Enterprise Value = 21.2m USD (38.2m + Debt 3.38m - CCE 20.4m)
Interest Coverage Ratio = -93.88 (Ebit TTM -29.4m / Interest Expense TTM 313.0k)
EV/FCF = -0.81x (Enterprise Value 21.2m / FCF TTM -26.3m)
FCF Yield = -124.0% (FCF TTM -26.3m / Enterprise Value 21.2m)
FCF Margin = -226.4% (FCF TTM -26.3m / Revenue TTM 11.6m)
Net Margin = -256.1% (Net Income TTM -29.7m / Revenue TTM 11.6m)
Gross Margin = -37.48% ((Revenue TTM 11.6m - Cost of Revenue TTM 16.0m) / Revenue TTM)
Gross Margin QoQ = -53.34% (prev -37.03%)
Tobins Q-Ratio = 0.52 (Enterprise Value 21.2m / Total Assets 41.1m)
Interest Expense / Debt = 1.75% (Interest Expense 59.0k / Debt 3.38m)
Taxrate = 21.0% (US default 21%)
NOPAT = -23.2m (EBIT -29.4m * (1 - 21.00%)) [loss with tax shield]
Current Ratio = 3.62 (Total Current Assets 25.8m / Total Current Liabilities 7.13m)
Debt / Equity = 0.13 (Debt 3.38m / totalStockholderEquity, last quarter 26.9m)
Debt / EBITDA = 0.64 (negative EBITDA) (Net Debt -17.0m / EBITDA -26.7m)
Debt / FCF = 0.65 (negative FCF - burning cash) (Net Debt -17.0m / FCF TTM -26.3m)
Total Stockholder Equity = 19.0m (last 4 quarters mean from totalStockholderEquity)
RoA = -90.12% (Net Income -29.7m / Total Assets 41.1m)
RoE = -156.6% (Net Income TTM -29.7m / Total Stockholder Equity 19.0m)
RoCE = -127.8% (out of range, set to none) (EBIT -29.4m / Capital Employed (Equity 19.0m + L.T.Debt 4.00m))
RoIC = -97.76% (negative operating profit) (NOPAT -23.2m / Invested Capital 23.7m)
WACC = 11.41% (E(38.2m)/V(41.6m) * Re(12.30%) + D(3.38m)/V(41.6m) * Rd(1.75%) * (1-Tc(0.21)))
Discount Rate = 12.30% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 133.5%
Fair Price DCF = unknown (Cash Flow -26.3m)
EPS Correlation: -21.80 | EPS CAGR: -1.46% | SUE: -0.14 | # QB: 0
Revenue Correlation: 74.22 | Revenue CAGR: 41.76% | SUE: 0.79 | # QB: 0
EPS next Quarter (2026-03-31): EPS=-0.67 | Chg30d=+0.065 | Revisions Net=+2 | Analysts=2
EPS next Year (2026-12-31): EPS=-2.63 | Chg30d=+0.083 | Revisions Net=+1 | Growth EPS=+29.5% | Growth Revenue=+31.0%